World ADC 2024
San Deigo San Diego, CA, United StatesJoin Discovery at World ADC, November 4-7 in San Diego. Be sure to stop by Booth 502 and meet with your experts: Emer Clarke, PhD, VP, Cell Biology Christina Moskowitz, […]
Cytochrome P450 and UGT induction studies to predict drug-drug interaction.
We have 20+ years of expertise in regulatory compliant ADME services. We provide in-process communication, IND submission-ready reports, and reliable results using Gentest® products and services.
Robust Dynamic Range to Assess Induction Response
Flexibility to use multiple inducers or assays for the same enzyme with robust analytical sensitivity. Mean and standard deviation of fold induction of enzyme activity in 3 donors after treatment of 50 μM omeprazole (OME), 20 μM ß-naphthoflavone (BNF), 1 mM phenobarbital (PB), or 10 μM rifampicin (RIF). Enzyme activities measured were phenacetin O-deethylase, S-mephenytoin N-demethylase, bupropion hydroxylase, amodiaquine N-deethylase, diclofenac 4’-hydroxylase, S-mephenytoin 4’-hydroxylase, and testosterone 6ß-hydroxylase.
Reproducible Induction Response in Gentest® Inducible-qualified Human Cryo-hepatocytes
Omeprazole-induced CYP1A2 catalytic activity in Gentest® Inducible-qualified human cryo-hepatocytes on 7 independent days
Highly reproducible, robust data. Phenacetin O-deethylase activity in a single donor (lot 246) of Gentest® Inducible-qualified human cryopreserved hepatocytes in 7 independent experiments conducted over the span of 18 weeks. Cells were treated with 50 μM omeprazole (OME) for 2 days prior to determination of enzyme activity. The amount of acet- aminophen metabolite formation was determined by incubating cells with 100 μM phenacetin for 30 minutes.
Zhang JG, et al (2014). Evaluation of calibration curve-based approaches to predict clinical inducers and non-inducers of CYP3A4 with plated human hepatocytes. Drug Metab. Dispos. 42:1379-1391.
Wong, S.G. et al (2021). Considerations from the innovation and quality induction working group in response to drug-drug interaction guidance from regulatory agencies: Guidelines on model fitting and recommendations on time course for in vitro cytochrome P450 induction studies including impact on drug interaction risk assessment. Drug Metab. Dispos. 49:94-110.
Join Discovery at World ADC, November 4-7 in San Diego. Be sure to stop by Booth 502 and meet with your experts: Emer Clarke, PhD, VP, Cell Biology Christina Moskowitz, […]
Join Discovery Life Sciences at ASHG 2024 November 5-9, 2024 | Colorado Convention Center, Denver, Colorado Schedule a Meeting at ASHG
Visit Discovery at Booth #919 during SITC 2024 November 6-10, 2024 | George R. Brown Convention Center, Houston, Texas View Discovery's Poster Presentation at SITC 2024 Presented by Dr. Dirk […]
Copyright © 2024 Discovery Life Sciences. All rights reserved.
Designed & Developed by Altitude Marketing